Back to Research Hub
Adaptive Biotechnologies Corporation
ADPT
$17.36+0.66 (+3.95%)
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new…
StreetsValue research for Adaptive Biotechnologies Corporation (ADPT)
Members get the full report for Adaptive Biotechnologies Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.